Next Article in Journal
Comparison of COVID-19 Resilience Index and Its Associated Factors across 29 Countries during the Delta and Omicron Variant Periods
Next Article in Special Issue
Early Clinical Experience with Molnupiravir for Mild to Moderate Breakthrough COVID-19 among Fully Vaccinated Patients at Risk for Disease Progression
Previous Article in Journal
Sputnik V Effectiveness against Hospitalization with COVID-19 during Omicron Dominance
Previous Article in Special Issue
Balancing Benefits and Harms of COVID-19 Vaccines: Lessons from the Ongoing Mass Vaccination Campaign in Lombardy, Italy
 
 
Article

Article Versions Notes

Vaccines 2022, 10(6), 939; https://doi.org/10.3390/vaccines10060939
Action Date Notes Link
article xml file uploaded 13 June 2022 10:07 CEST Original file -
article xml uploaded. 13 June 2022 10:07 CEST Update -
article pdf uploaded. 13 June 2022 10:07 CEST Version of Record -
article supplementary file uploaded. 13 June 2022 10:07 CEST - https://www.mdpi.com/2076-393X/10/6/939#supplementary
article html file updated 13 June 2022 10:09 CEST Original file -
article xml file uploaded 13 June 2022 10:16 CEST Update -
article xml uploaded. 13 June 2022 10:16 CEST Update https://www.mdpi.com/2076-393X/10/6/939/xml
article pdf uploaded. 13 June 2022 10:16 CEST Updated version of record https://www.mdpi.com/2076-393X/10/6/939/pdf
article html file updated 13 June 2022 10:18 CEST Update -
article html file updated 12 August 2022 20:04 CEST Update https://www.mdpi.com/2076-393X/10/6/939/html
Back to TopTop